ANNX
NASDAQ
$5.39
Annexon Inc (ANNX)
Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for autoimmune and neurodegenerative diseases. The company is headquartered in South San Francisco, California.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $14.88 (+176.07%)
Market Cap
$1.26B
FCF 5Y CAGR
+23.18%
Free Cash Flow Yield
-14.51%
Beta (5Y)
1.22
Price Chart
Valuation
Market Cap$1.26B
P/B4.45
Profitability
EBITDA-$203M
EPS-$1.29
Financial Health
Free Cash Flow Yield-14.51%
Growth & Risk
FCF 5Y CAGR+23.18%
Beta (5Y)1.22
Sharpe Ratio1.40